| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0068 | 1 |